Biomarin Pharmaceutical Inc. (0HNC)
Market Open
10 Aug, 15:27
$
68. 41
+5.11
+8.0727%
$
- Market Cap
126.18 P/E Ratio
- Div Yield
4,101 Volume
1 Eps
$ 63.3
Previous Close Want to track 0HNC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biomarin Pharmaceutical Inc. (0HNC) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.66B
Trailing P/E (ttm) 167.92
Forward P/E -
PEG ratio -1.89
Price/Sales (ttm) 3.62
Price/Book (mrq) 1.95
Enterprise Value/Revenue 4.6
Enterprise Value/EBITDA 136.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 990
Average volume (90 days) 712
Price summary
52-Week low 49.39
52-Week high 69.24
Beta -
50-Day moving average 59.21
200-Day moving average 57.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.02%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 17.65
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.53
Total debt (mrq) -
Total Debt/Equity (mrq) 0.66
Current ratio (mrq) 2.39%
Book value per share (mrq) 32.76
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
